University of Washington biochemist David Baker has won a share of this year’s Nobel Prize in chemistry for more than two decades of discoveries about the molecular structure of proteins… Read More
Nearly a decade ago, radio chemists at the nuclear power startup TerraPower saw a promising opportunity in radioactive waste from Cold War weapons. And when you work for a company… Read More
Four national cancer research organizations, spearheaded by Seattle’s Fred Hutch Cancer Center, will work together in an unprecedented alliance to use artificial intelligence to battle cancer. The newly established Cancer… Read More
Seattle-based biotech company Athira Pharma is laying off 49 people, or about 70% of its workforce, as part of cost-cutting measures and a restructuring. Athira, which went public in 2020,… Read More
Arzeda, a protein design startup that generates new enzymes for industrial, agricultural and other applications, announced a $38 million investment round. The Seattle-based company creates blueprints for enzymes using protein… Read More
Viome, a company selling microbiome products and health diagnostics, announced Tuesday that it raised $25 million from investors and hired Kal Raman as its chief operating officer. The Bellevue, Wash.-based… Read More
Sonoma Biotherapeutics on Wednesday announced that it received a $45 million payment from Regeneron Pharmaceuticals for meeting a significant milestone in its efforts to research, develop and commercialize therapies for… Read More
Talus Bioscience on Tuesday announced $11.2 million in venture capital funding to advance its drug discovery program for hard-to-treat diseases. The Seattle biotech’s platform brings biochemical analysis into living cells,… Read More
Alpenglow Biosciences, a Seattle biotech startup that develops 3D spatial biology imaging technology, announced Thursday that it landed a $2 million research grant from the National Institute of Health, and… Read More
In a laboratory near downtown Seattle on the shores of Lake Union, Hetu Kamisetty is helping build what he says is the biotech company of the future. If talent, money… Read More
Sana Biotechnology celebrated the beginning of a new chapter on its journey to make drugs that treat complicated diseases, cutting the ribbon outside the company’s new manufacturing facility in Bothell,… Read More
Outpace Bio, a Seattle startup using artificial intelligence to design proteins that are incorporated into cancer therapies targeting solid tumors, has raised $144 million in new cash from investors. The… Read More
If Elon Musk’s Neuralink brain-implant venture succeeds in its effort to create next-generation brain implants for artificial vision, the devices could bring about a breakthrough for the visually impaired —… Read More
The Allen Institute’s OpenScope program lets scientists study the weird workings of the brain — for instance, how magic mushrooms work their psychedelic magic on individual neurons, how memories of the past… Read More
Bonum Therapeutics is moving into new offices near Seattle’s South Lake Union neighborhood and plans to double its headcount in pursuit of immunotherapy drugs. The biotech startup will occupy the 11th floor… Read More
Viome, the Bellevue, Wash.-based wellness and diagnostics company, is putting its efforts around preventive healthcare and longevity where its mouth is. The company unveiled new toothpaste and gel products Wednesday… Read More
Seattle’s Aurion Biotech announced Wednesday that it received special designations from the U.S. Food and Drug Administration that should speed up the development of its treatment for a common disease… Read More
Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software technology, with the potential of supporting innovation in drug development, agriculture, synthetic biology… Read More
The ability to call your doctor’s office and speak to a live human appears to be a thing of the past as patients turn to digital communications. Yet options there… Read More
Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced an expanded $71 million Series A investment round. The 2-year-old company, which has operations… Read More
Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for diagnosing cancer, based on an analysis of more than a… Read More
A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s… Read More
The Allen Institute for Immunology, a division of the Seattle-based Allen Institute, is teaming with Seattle Children’s Research Institute to launch a study aimed at understanding the origins of inflammatory… Read More
Seattle startup Dopl Technologies has developed a telerobotic ultrasound system intended to bring specialist care to patients in rural areas. Dopl’s mission is to eliminate the long distances that some… Read More
“Everyone poops,” declares the classic children’s book used by parents, including me, to help their kids understand what is a natural part of all animals’ lives. “Everyone poops — and… Read More
The University of Washington’s Institute for Protein Design is on a hot streak. New studies, companies and spinouts are emerging at a rapid clip from the research hub, propelled by… Read More
The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business models driven by AI were all topics at a panel… Read More
Travis Rush grew up in the tiny seaside town of Gold Beach in Southern Oregon. With a population of only 1,576 — as was proudly proclaimed on the sign coming… Read More
Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion in cash, a 38% premium over Alpine’s closing price on… Read More
A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that the diagnostic caught the neurodegenerative disease in 100% of the… Read More
